SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-21-001155
Filing Date
2021-05-28
Accepted
2021-05-28 16:32:23
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-3 a2243263zf-3.htm F-3 439282
2 EX-4.4 a2243263zex-4_4.htm EX-4.4 485370
3 EX-5.1 a2243263zex-5_1.htm EX-5.1 67447
4 EX-23.1 a2243263zex-23_1.htm EX-23.1 3546
5 EX-23.2 a2243263zex-23_2.htm EX-23.2 3210
6 G859539.JPG g859539.jpg GRAPHIC 15381
7 G726822.JPG g726822.jpg GRAPHIC 53334
8 G161682LUI001.JPG g161682lui001.jpg GRAPHIC 6105
9 G161682LUI002.JPG g161682lui002.jpg GRAPHIC 10010
  Complete submission text file 0001047469-21-001155.txt   1117290
Mailing Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006
Business Address 801 BIXING STREET BIHU COUNTY LISHUI, ZHEJIANG PROVINCE F4 323006 8657820516666
AnPac Bio-Medical Science Co., Ltd. (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: F-3 | Act: 33 | File No.: 333-256630 | Film No.: 21980829
SIC: 8071 Services-Medical Laboratories